AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzab M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Neucure Lifesciences Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimzab M 1mg/500mg Tablet

Diabetic patients with type 2 mellitus may find relief with Glimepiride/Metformin 1mg/500mg tablets, a dual-action antidiabetic medication. This combined formulation helps regulate blood glucose in adults. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; abrupt cessation can lead to hyperglycemia and potentially serious complications like renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is a component of a broader diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (rapid-acting glucose sources like juice or candy). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Consult your physician before initiating treatment if you have a history of cardiovascular disease; it might not be suitable for you. Pregnant or lactating individuals must seek medical counsel prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimzab M 1mg/500mg Tablet

There is no text provided to rephrase.

Uses of Glimzab M 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimzab M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimzab M 1mg/500mg tablets should be administered with a meal.

Common Side effects of Glimzab M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimzab M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glimzab M 1mg/500mg tablets should be administered with food.

How Glimzab M 1mg/500mg Tablet works:

Glimzab M, a 1mg/500mg tablet, unites glimepiride and metformin to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimzab M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimzab M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Using Glimzab M 1mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimzab M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimzab M 1mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimzab M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; Glimzab M 1mg/500mg tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimzab M 1mg/500mg Tablet :

Should you forget a Glimzab M 1mg/500mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimzab M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimzab M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimzab M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimzab M 1mg/500mg Tablets and seek immediate medical attention.
Glimzab M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimzab M 1mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimzab M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimzab M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimzab M 1mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimzab M 1mg/500mg Table...
65
MRP 75
13% off